AAAAAA

   
Results: 1-25 | 26-50 | 51-54
Results: 1-25/54
c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations
Authors: D'Cruz, CM Gunther, EJ Boxer, RB Hartman, JL Sintasath, L Moody, SE Cox, JD Ha, SI Belka, GK Golant, A Cardiff, RD Chodosh, LA
Citation: Cm. D'Cruz et al., c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations, NAT MED, 7(2), 2001, pp. 235-239
Fluorescence detection of nitrogen dioxide with perylene/PMMA thin films
Authors: Sasaki, DY Singh, S Cox, JD Pohl, PI
Citation: Dy. Sasaki et al., Fluorescence detection of nitrogen dioxide with perylene/PMMA thin films, SENS ACTU-B, 72(1), 2001, pp. 51-55
Long-term results with radiotherapy for stage I-II follicular lymphomas
Authors: Wilder, RB Jones, D Tucker, SL Fuller, LM Ha, CS McLaughlin, P Hess, MA Cabanillas, F Cox, JD
Citation: Rb. Wilder et al., Long-term results with radiotherapy for stage I-II follicular lymphomas, INT J RAD O, 51(5), 2001, pp. 1219-1227
Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: Long-term follow-up and patterns of failure
Authors: Liao, ZX Ha, CS Vlachaki, MT Hagemeister, F Cabanillas, F Hess, M Tucker, S Cox, JD
Citation: Zx. Liao et al., Mantle irradiation alone for pathologic stage I and II Hodgkin's disease: Long-term follow-up and patterns of failure, INT J RAD O, 50(4), 2001, pp. 971-977
Biology-based combined-modality radiotherapy: Workshop report
Authors: Mason, KA Komaki, R Cox, JD Milas, L
Citation: Ka. Mason et al., Biology-based combined-modality radiotherapy: Workshop report, INT J RAD O, 50(4), 2001, pp. 1079-1089
Radiation therapy after a partial response to chop chemotherapy for aggressive lymphomas
Authors: Wilder, RB Rodriguez, MA Tucker, SL Ha, CS Hess, MA Cabanillas, FF Cox, JD
Citation: Rb. Wilder et al., Radiation therapy after a partial response to chop chemotherapy for aggressive lymphomas, INT J RAD O, 50(3), 2001, pp. 743-749
The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21)
Authors: Ha, CS Tucker, SL Lee, MS McLaughlin, P Cabanillas, F Cox, JD
Citation: Cs. Ha et al., The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21), INT J RAD O, 49(3), 2001, pp. 727-732
Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to chop-based induction chemotherapy
Authors: Wilder, RB Tucker, SL Ha, CS Rodriguez, MA Hess, MA Cabanillas, FF Cox, JD
Citation: Rb. Wilder et al., Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to chop-based induction chemotherapy, INT J RAD O, 49(1), 2001, pp. 17-22
Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment
Authors: Pelloski, CE Wilder, RB Ha, CS Hess, MA Cabanillas, FF Cox, JD
Citation: Ce. Pelloski et al., Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment, RADIOTH ONC, 59(2), 2001, pp. 145-151
Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer
Authors: Rosen, II Fischer, TA Antolak, JA Starkschall, G Travis, EL Tucker, SL Hogstrom, KR Cox, JD Komaki, R
Citation: Ii. Rosen et al., Correlation between lung fibrosis and radiation therapy dose after concurrent radiation therapy and chemotherapy for limited small cell lung cancer, RADIOLOGY, 221(3), 2001, pp. 614-622
Subunit-subunit interactions in trimeric arginase - Generation of active monomers by mutation of a single amino acid
Authors: Lavulo, LT Sossong, TM Brigham-Burke, MR Doyle, ML Cox, JD Christianson, DW Ash, DE
Citation: Lt. Lavulo et al., Subunit-subunit interactions in trimeric arginase - Generation of active monomers by mutation of a single amino acid, J BIOL CHEM, 276(17), 2001, pp. 14242-14248
Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity
Authors: Gopal, R Ha, CS Tucker, SL Khouri, IF Giralt, SA Gajewski, JL Andersson, BS Cox, JD Champlin, RE
Citation: R. Gopal et al., Comparison of two total body irradiation fractionation regimens with respect to acute and late pulmonary toxicity, CANCER, 92(7), 2001, pp. 1949-1958
Hematologic recovery after central lymphatic irradiation for patients withstage I-II follicular lymphoma
Authors: Ha, CS Tucker, SL Blanco, AI Wilder, RB McLaughlin, P Cabanillas, F Cox, JD
Citation: Cs. Ha et al., Hematologic recovery after central lymphatic irradiation for patients withstage I-II follicular lymphoma, CANCER, 92(5), 2001, pp. 1074-1079
Treatment of unicentric and multicentric Castleman disease and the role ofradiotherapy
Authors: Chronowski, M Ha, CS Wilder, RB Cabanillas, F Manning, J Cox, JD
Citation: M. Chronowski et al., Treatment of unicentric and multicentric Castleman disease and the role ofradiotherapy, CANCER, 92(3), 2001, pp. 670-676
Localized non-Hodgkin lymphoma involving the thyroid gland
Authors: Ha, CS Shadle, KM Medeiros, LJ Wilder, RB Hess, MA Cabanillas, F Cox, JD
Citation: Cs. Ha et al., Localized non-Hodgkin lymphoma involving the thyroid gland, CANCER, 91(4), 2001, pp. 629-635
Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma
Authors: Wilder, RB Rodriguez, MA Ha, CS Pro, B Hess, MA Cabanillas, F Cox, JD
Citation: Rb. Wilder et al., Bulky disease is an adverse prognostic factor in patients treated with chemotherapy comprised of cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy for aggressive lymphoma, CANCER, 91(12), 2001, pp. 2440-2446
Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum
Authors: Kim, NN Cox, JD Baggio, RF Emig, FA Mistry, SK Harper, SL Speicher, DW Morris, SM Ash, DE Traish, A Christianson, DW
Citation: Nn. Kim et al., Probing erectile function: S-(2-boronoethyl)-L-cysteine binds to arginase as a transition state analogue and enhances smooth muscle relaxation in human penile corpus cavernosum, BIOCHEM, 40(9), 2001, pp. 2678-2688
Mechanistic and metabolic inferences from the binding of substrate analogues and products to arginase
Authors: Cox, JD Cama, E Colleluori, DM Pethe, S Boucher, JL Mansuy, D Ash, DE Christianson, DW
Citation: Jd. Cox et al., Mechanistic and metabolic inferences from the binding of substrate analogues and products to arginase, BIOCHEM, 40(9), 2001, pp. 2689-2701
The management of superior sulcus tumors
Authors: Komaki, R Putnam, JB Walsh, G Lee, JS Cox, JD
Citation: R. Komaki et al., The management of superior sulcus tumors, SEM SURG ON, 18(2), 2000, pp. 152-164
Evidence in oncology - The Janeway Lecture 2000
Authors: Cox, JD
Citation: Jd. Cox, Evidence in oncology - The Janeway Lecture 2000, CANCER J, 6(6), 2000, pp. 351-357
Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC):Identification of five groups with different survival
Authors: Werner-Wasik, M Scott, C Cox, JD Sause, WT Byhardt, RW Asbell, S Russell, A Komaki, R Lee, JS
Citation: M. Werner-wasik et al., Recursive partitioning analysis of 1999 radiation therapy oncology group (RTOG) patients with locally-advanced non-small-cell lung cancer (LA-NSCLC):Identification of five groups with different survival, INT J RAD O, 48(5), 2000, pp. 1475-1482
Impact of involved field radiotherapy after chop-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas
Authors: Schlembach, PJ Wilder, RB Tucker, SL Ha, CS Rodriguez, MA Hess, MA Cabanillas, FF Cox, JD
Citation: Pj. Schlembach et al., Impact of involved field radiotherapy after chop-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas, INT J RAD O, 48(4), 2000, pp. 1107-1110
Outcome predictors for 143 patients with superior sulcus tumors treated bymultidisciplinary approach at the University of Texas M. D. Anderson Cancer Center
Authors: Komaki, R Roth, JA Walsh, GL Putnam, JB Vaporciyan, A Lee, JS Fossella, FV Chasen, M Delclos, ME Cox, JD
Citation: R. Komaki et al., Outcome predictors for 143 patients with superior sulcus tumors treated bymultidisciplinary approach at the University of Texas M. D. Anderson Cancer Center, INT J RAD O, 48(2), 2000, pp. 347-354
Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmaticpresentation: Natural history and patterns of disease progression
Authors: Liao, ZX Ha, CS McLaughlin, P Manning, JT Hess, M Cabanillas, F Cox, JD
Citation: Zx. Liao et al., Mucosa-associated lymphoid tissue lymphoma with initial supradiaphragmaticpresentation: Natural history and patterns of disease progression, INT J RAD O, 48(2), 2000, pp. 399-403
The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum
Authors: Nguyen, LN Ha, CS Hess, M Romaguera, JE Manning, JT Cabanillas, F Cox, JD
Citation: Ln. Nguyen et al., The outcome of combined-modality treatments for stage I and II primary large B-cell lymphoma of the mediastinum, INT J RAD O, 47(5), 2000, pp. 1281-1285
Risultati: 1-25 | 26-50 | 51-54